Treading the beaten path with old and new obstacles: a report from the Indian HIPEC registry-Reference-Cited by-同舟云学术

Treading the beaten path with old and new obstacles: a report from the Indian HIPEC registry

Published:2018-10-09 Issue:1 Volume:35 Page:361-369
ISSN:0265-6736
Container-title:International Journal of Hyperthermia
language:en
Short-container-title:International Journal of Hyperthermia

Author:

Bhatt Aditi¹,Mehta Sanket S.²,Zaveri Shabber³,Rajan Firoz⁴,Ray Mukurdipi⁵,Sethna Kayomarz⁶,Katdare Ninad⁷,Patel Mahesh D.⁸,Kammar Praveen⁹,Prabhu Robin¹,Sinukumar Snita¹⁰,Mishra Suniti¹¹,Rangarajan Bharath¹²,Rangole Ashvin¹³,Damodaran Dileep¹⁴,Penumadu Prasanth¹⁵,Ganesh Mandakulutur¹⁶,Peedicayil Abraham¹⁷,Raj Hemant¹⁸,Seshadri Ramakrishnan¹⁸

Affiliation:

1. Department of Surgical Oncology, Fortis Hospital, Bangalore, India;

2. Department of Peritoneal surface oncology, Saifee Hospital, Mumbai, India;

3. Department of Surgical Oncology, Manipal Hospital, Bangalore, India;

4. Department of Surgical Oncology, Kovai Medical Center, Coimbatore, India;

5. Department of Surgical Oncology, All India Institute of Medical Sciences, New Delhi, India;

6. Department of Surgery, Lokmanya Tilak Municipal medical college and general hospital, Mumbai, India;

7. Department of Surgical Oncology, SL Raheja hospital, Mumbai, India;

8. Department of Surgical Oncology, Zydus Hospital, Ahmedabad, India;

9. Department of Surgical Oncology, Global hospitals, Hyderabad, India;

10. Department of Surgical oncology, Jehangir Hospital, Pune, India;

11. Department of Pathology, Fortis Hospital, Bangalore, India;

12. Department of Medical oncology, Kovai Medical center, Coimbatore, India;

13. Department of Surgical oncology, CHL, CBCC cancer center, Indore, India;

14. Department of Surgical oncology, MVR cancer center and research Institute, Calicut, India;

15. Department of Surgical oncology, Jawarharlal Institute of Postgraduate Medical Education and Research (JIPMER), Puducherry, India;

16. Department of Surgical Oncology, Vaidehi Institute of Medical sciences, Bangalore, India;

17. Department of Gynecologic Oncology, Christian Medical College, Vellore, India;

18. Department of Surgical Oncology, Cancer Institute (WIA), Chennai, India

Publisher

Informa UK Limited

Subject

Cancer Research,Physiology (medical),Physiology

Link

https://www.tandfonline.com/doi/pdf/10.1080/02656736.2018.1503345

Reference34 articles.

1. Patients with Peritoneal Carcinomatosis from Gastric Cancer Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Is Cure a Possibility?

2. Is There a Possibility of a Cure in Patients With Colorectal Peritoneal Carcinomatosis Amenable to Complete Cytoreductive Surgery and Intraperitoneal Chemotherapy?

3. Diffuse malignant peritoneal mesothelioma: Long-term survival with complete cytoreductive surgery followed by hyperthermic intraperitoneal chemotherapy (HIPEC)

4. Decision-making and technical factors account for the learning curve in complex surgery

5. The Initial Indian Experience with Cytoreductive Surgery and HIPEC in the Treatment of Peritoneal Metastases

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Perioperative outcomes and platinum resistant recurrence in patients undergoing systematic, protocol-based, total parietal peritonectomy during interval cytoreductive surgery for advanced ovarian cancer: results of the TORPEDO study;Journal of Gynecologic Oncology;2024

2. Adoption of cytoreductive surgery in the management of peritoneal malignancies—Global trends;Journal of Surgical Oncology;2023-10-11

3. Perioperative outcomes and platinum resistant recurrence in patients undergoing protocol based total parietal peritonectomy during interval cytoreductive surgery for advanced ovarian cancer- results of the TORPEDO study;2023-10-09

4. Long-Term Survival in Patients Treated by Cytoreductive Surgery with or Without HIPEC for Peritoneal Surface Malignancies—A report from the Indian HIPEC Registry;Indian Journal of Surgical Oncology;2023-03-09

5. Enhanced recovery after surgery (ERAS) in cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC): a cross-sectional survey;Pleura and Peritoneum;2021-06-21